Liver Transplant

Liver Transplant

The Center for Liver Disease and Transplantation at NewYork-Presbyterian is a multidisciplinary program dedicated to the treatment of adults and children with all stages of liver disease. We provide comprehensive services, including diagnostic testing, medical treatment, surgery, transplantation, and support. Our transplantation services are available for people with advanced liver disease who cannot be successfully treated using other approaches. We have performed more than 2,000 liver transplants, with outcomes that meet or surpass national and regional averages. Our transplant rate (likelihood of getting a transplant) far exceeds all other programs in the Region leading to the lowest risk of dying on the waiting list. People come to us from across the nation and around the world for our renowned care.

A Team of Liver Transplantation Experts for Every Phase of Care

When you or your loved one comes to us for a liver transplant, we bring together the specialists needed to provide care at every step of the journey. Our liver transplant team includes hepatologists (liver experts), gastroenterologists, hepatobiliary surgeons, oncologists, radiology and pathology experts, advanced practice nurses, physician assistants, transplant coordinators, psychiatrists, social workers, pharmacists, nutritionists, and research coordinators. Together with other specialists at NYP, this team of highly trained specialists address all of your and your families concerns and provide the latest treatment options available. Our entire team is here to ensure that you are confident that you are receiving the best care in the world.

Experience Treating All Types of Liver Disease

No matter what your liver disease, we have experience treating it. We care for people with:

  • Acute liver failure
  • Alcoholic liver disease
  • Amyloidosis of the liver
  • Autoimmune hepatitis (where your body attacks its liver)
  • Biliary atresia (a life-threatening condition in infants in which the bile ducts inside or outside the liver do not have normal openings)
  • Hepatocellular carcinoma and cholangiocarcinoma (liver and bile duct cancer)
  • Fatty liver disease or NASH
  • Cystic fibrosis, alpha-1-antitrypsin deficiency, and other genetic liver conditions
  • Drug-induced liver failure
  • Hemochromatosis (abnormally high blood iron levels)
  • Hepatoblastoma and other benign and malignant liver tumors
  • Primary biliary and primary sclerosing cholangitis (inflammation of the bile ducts, causing scarring)
  • Wilson's disease (a genetic disease that prevents the body from removing extra copper, resulting in high levels of copper that can cause organ damage)
  • Viral hepatitis, including hepatitis B and C

Your Best Chance for Getting a Liver Transplant

At NewYork-Presbyterian, you are ten times more likely to receive a liver transplant than at other hospitals in the region, with an average wait time of just nine months. Our doctors use a variety of approaches to provide the greatest number of transplants possible given the limited supply of organs.

  • Split liver transplantation. Since the liver has a unique ability to regenerate itself, our surgeons can sometimes divide one donated liver so that it can be used to transplant two different patients. Both patients benefit from one donor organ. Called "split liver" or "partial liver" transplantation, this resourceful allocation of scarce donor organs enables more people to receive transplants. Surgeons at NewYork-Presbyterian were among the first to perform split liver transplantation.
  • Living donor liver transplantation. The Living Donor Liver Transplant (LDLT) Program at NewYork-Presbyterian is one of the largest and most experienced programs in North America, and the only one offering laparoscopic donor surgery for most donors. Up to one in five of our transplant recipients receives a liver from a living donor. During living donor liver transplantation, our surgeons remove a portion of a healthy living person's liver for transplantation into a recipient. The partial liver regenerates, grows and remodels in both the donor and recipient to form two complete, functioning organs. Our team was a leader in the NIH-funded A2ALL study which defined new ways to save lives with LDLT.
  • Auxiliary liver transplantation. Patients with acute liver failure, usually due to a medication overdose or virus, traditionally have had limited options. With auxiliary liver transplantation, surgeons attach a portion of a healthy donor's liver to a portion of a recipient's diseased liver. The donor liver supports the recipient during recovery, clearing toxins and preventing brain injury. If the patient's own "native" liver recovers, the donor liver is no longer required, anti-rejection medication can be stopped, and the donor liver shrinks. Whereas liver transplantation requires patients to take immunosuppressant medications for the remainder of their lives, auxiliary transplantation does not. NewYork-Presbyterian was one of the first institutions to perform this procedure, which now accounts for a substantial proportion of liver transplants in children with acute liver failure and is also an option for some young adults.

A Variety of Locations

We transplant livers into adult patients at NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Weill Cornell Medical Center. Children can receive a liver transplant at NewYork-Presbyterian Morgan Stanley Children's Hospital. You can also receive care before and after your transplant at a number of our convenient office locations in Midtown Manhattan, Lower Manhattan, Westchester and Rockland Counties, and New Jersey.

Innovating Liver Transplantation

We have a deep commitment to clinical innovation, which is made possible by a dynamic partnership between our physicians and academic researchers. Our team has expanded transplantation for people with:

  • Hepatitis C. Our team has led the development and approval of the new all-oral direct acting antiviral agents in the pre- and post-transplant setting, preventing recurrence of the virus and sometimes obviating the need for transplant. NewYork-Presbyterian is one of very few institutions to provide transplantation for people co-infected with hepatitis C and HIV and participates in the HOPE act to provide improved access for HIV + patients requiring transplantation.
  • Liver cancer. Numerous clinical trials have yielded methods to reduce the size of tumors, and in so doing, render patients eligible for transplantation. New York-Presbyterian is one of very centers that has protocols to transplant cancer of the bile ducts, and certain rare cancers iof the liver (eg neuroendocrine tumors) that have high recurrence rates without intensive therapy before transplantation.
  • Fatty liver disease. Both the NewYork-Presbyterian/Columbia University Irving Medical Center and NewYork-Presbyterian/Weill Cornell Medical Center are investigating novel, new therapies for fatty liver disease in adults and children, including treatments that remove fat and improve fibrosis (scarring) in patients who suffer from this complication. Given the epidemic of NASH (fatty liver disease), research to prevent the need for transplant is desperately needed.

Lifelong Follow-Up and Support

Transplantation is a life-altering procedure. You'll need life-long immunosuppressant medications and careful monitoring. Throughout the transplant process and beyond, we partner closely with donors, recipients, and their referring physicians to achieve a seamless continuum of care, while helping you and your family navigate any emotional, financial, and logistical concerns you may have. Our transplant teams are here for you—for life.

Contact

NewYork-Presbyterian/
Columbia University Medical Center

Center for Liver Disease and Transplantation
Phone: 877-LIVER-MD (877-548-3763)

NewYork-Presbyterian/
Weill Cornell Medical Center

Center for Liver Disease and Transplantation
Phone: 646-962-LIVER (646-962-5483)